Molecular Templates Inc (NASDAQ:MTEM) shares traded -3.79% lower at $0.33 on Wall Street last session.
MTEM stock price is now -75.87% away from the 50-day moving average and -83.82% away from the 200-day moving average. The market capitalization of the company currently stands at $2.14M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $12, BofA Securities recently initiated with Buy rating for Molecular Templates Inc (NASDAQ: MTEM). On February 01, 2021, UBS recently initiated its ‘Neutral’ rating on the stock quoting a target price of $13, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, BIOTECH TARGET N V, 10% Owner bought 250,000 shares of the company’s stock on Apr 02 ’24. The stock was bought for $587,500 at an average price of $2.35. Upon completion of the transaction, the 10% Owner now directly owns 1,279,820 shares in the company, valued at $0.42 million. A total of 17.39% of the company’s stock is owned by insiders.
During the past 12 months, Molecular Templates Inc has had a low of $0.29 and a high of $6.69. As of last week, the company has a debt-to-equity ratio of 1.55, a current ratio of 1.56, and a quick ratio of 1.56. The fifty day moving average price for MTEM is $1.369 and a two-hundred day moving average price translates $2.02525 for the stock.
The latest earnings results from Molecular Templates Inc (NASDAQ: MTEM) was released for 2024-06-30. The net profit margin was -61.35% and return on equity was -929.14% for MTEM. The company reported revenue of $0.57 million for the quarter, compared to $6.87 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -91.67 percent.
